Published in Cancer Res on August 01, 2001
Cancer drug resistance: an evolving paradigm. Nat Rev Cancer (2013) 6.77
Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov (2010) 4.66
Mechanisms of Taxol resistance related to microtubules. Oncogene (2003) 3.16
Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol (2011) 2.43
Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res (2012) 1.39
Microtubules and their role in cellular stress in cancer. Front Oncol (2014) 1.15
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res (2010) 1.14
The roles of beta-tubulin mutations and isotype expression in acquired drug resistance. Cancer Inform (2007) 0.98
Clinical proteomics: present and future prospects. Clin Biochem Rev (2006) 0.97
Beta class II tubulin predominates in normal and tumor breast tissues. Breast Cancer Res (2003) 0.97
New insights into mechanisms of resistance to microtubule inhibitors. Biochim Biophys Acta (2011) 0.96
LIMK2 mediates resistance to chemotherapeutic drugs in neuroblastoma cells through regulation of drug-induced cell cycle arrest. PLoS One (2013) 0.90
Nek4 status differentially alters sensitivity to distinct microtubule poisons. Cancer Res (2010) 0.88
Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens. J Pharmacol Exp Ther (2011) 0.88
A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis. Mol Ther (2012) 0.88
Conformational analysis of the carboxy-terminal tails of human beta-tubulin isotypes. Biophys J (2007) 0.88
Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines. Int J Oncol (2011) 0.87
Resistance to microtubule-stabilizing drugs involves two events: beta-tubulin mutation in one allele followed by loss of the second allele. Cell Cycle (2005) 0.87
Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation. Biochem Pharmacol (2011) 0.87
Oblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulins. Sci Rep (2015) 0.86
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? Anal Cell Pathol (Amst) (2015) 0.86
Structural evidence for cooperative microtubule stabilization by Taxol and the endogenous dynamics regulator MAP4. ACS Chem Biol (2012) 0.85
Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest. PLoS One (2011) 0.85
The effect of beta-elemene on alpha-tubulin polymerization in human hepatoma HepG2 cells. Chin J Cancer Res (2013) 0.82
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial. Cancer Chemother Pharmacol (2015) 0.81
Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin. Cancer Chemother Pharmacol (2007) 0.80
CKD-516 displays vascular disrupting properties and enhances anti-tumor activity in combination with chemotherapy in a murine tumor model. Invest New Drugs (2013) 0.79
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia. Pharmacogenomics (2014) 0.79
Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity. J Med Chem (2015) 0.78
Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol (2006) 0.77
Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents. Bioorg Med Chem Lett (2015) 0.75
Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line. Korean J Hematol (2012) 0.75
The RhoGAP protein ARHGAP18/SENEX localizes to microtubules and regulates their stability in endothelial cells. Mol Biol Cell (2017) 0.75
An In silico Based Comparison of Drug Interactions in Wild and Mutant Human β-tubulin through Docking Studies. Avicenna J Med Biotechnol (2014) 0.75
Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability. Cell Cycle (2016) 0.75
A novel synthetic 1,3-phenyl bis-thiourea compound targets microtubule polymerization to cause cancer cell death. Cancer Biol Ther (2014) 0.75
Targeting mitotic pathways for endocrine-related cancer therapeutics. Endocr Relat Cancer (2017) 0.75
Promotion of microtubule assembly in vitro by taxol. Nature (1979) 12.73
Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A (1980) 8.94
Two Saccharomyces cerevisiae kinesin-related gene products required for mitotic spindle assembly. J Cell Biol (1992) 6.37
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A (1997) 4.20
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A (1997) 3.42
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest (1997) 2.96
Taxol binds to polymerized tubulin in vitro. J Cell Biol (1981) 2.86
Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J Microsc (2003) 2.74
Saccharomyces cerevisiae genes required in the absence of the CIN8-encoded spindle motor act in functionally diverse mitotic pathways. Mol Biol Cell (1997) 2.64
Submicrometer metallic barcodes. Science (2001) 2.62
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest (2001) 2.61
Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. Am J Epidemiol (1988) 2.60
The effect of aphidicolin on adenovirus DNA synthesis. Nucleic Acids Res (1979) 2.47
Detection of inbreeding effects by the chi-square test on genotypic and phenotypic frequencies. Am J Hum Genet (1980) 2.45
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35
Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst (1991) 2.33
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor. J Biol Chem (1991) 2.15
Ammonia acquisition in enteric bacteria: physiological role of the ammonium/methylammonium transport B (AmtB) protein. Proc Natl Acad Sci U S A (1998) 2.15
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol (1991) 2.08
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. J Clin Oncol (2000) 2.02
Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J Biol Chem (1990) 2.02
Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology (2005) 2.01
Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res (1998) 1.99
Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin Cancer Res (2000) 1.97
Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment. Ann Oncol (2008) 1.92
Taxol binds to cellular microtubules. J Cell Biol (1982) 1.91
Loss of function of Saccharomyces cerevisiae kinesin-related CIN8 and KIP1 is suppressed by KAR3 motor domain mutations. Genetics (1993) 1.89
Extraction of membrane proteins by differential solubilization for separation using two-dimensional gel electrophoresis. Electrophoresis (1998) 1.88
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors. J Biol Chem (1993) 1.88
Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol (2008) 1.84
Melanocortin 1 receptor variation in the domestic dog. Mamm Genome (2000) 1.83
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN). J Biol Chem (1999) 1.79
Nephrin is involved in podocyte maturation but not survival during glomerular development. Kidney Int (2007) 1.79
MELAS associated with mutations in the POLG1 gene. Neurology (2007) 1.77
Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia (1996) 1.76
A discrete-time model for the statistical analysis of infectious disease incidence data. Biometrics (1992) 1.75
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res (2001) 1.75
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene (2012) 1.74
Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem (1981) 1.74
Repeated embolism and multiple aneurysms: central nervous system manifestations of cardiac myxoma. Eur J Neurol (2008) 1.72
Comparison of HPV DNA vaccines employing intracellular targeting strategies. Gene Ther (2004) 1.72
Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate or microtubule-associated proteins. Biochemistry (1981) 1.71
A generalized stochastic model for the analysis of infectious disease final size data. Biometrics (1991) 1.71
Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med (1996) 1.70
High prevalence of bla(CTX-M) extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect (2010) 1.70
The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A (1988) 1.69
Protein identification with N and C-terminal sequence tags in proteome projects. J Mol Biol (1998) 1.68
A locus for bipolar affective disorder on chromosome 4p. Nat Genet (1996) 1.67
Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. Mol Pharmacol (1971) 1.66
The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell (2000) 1.63
Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1. Nat Genet (2001) 1.62
Clinical course and prognostic factors of clinical early IgA nephropathy. Neth J Med (2008) 1.61
Characterization of the Taxol binding site on the microtubule. Identification of Arg(282) in beta-tubulin as the site of photoincorporation of a 7-benzophenone analogue of Taxol. J Biol Chem (1999) 1.59
Characterization of the taxol binding site on the microtubule. 2-(m-Azidobenzoyl)taxol photolabels a peptide (amino acids 217-231) of beta-tubulin. J Biol Chem (1995) 1.56
3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin. J Biol Chem (1994) 1.53
A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem Biophys Res Commun (1976) 1.52
Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem (1989) 1.52
Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol (1992) 1.50
A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci U S A (1999) 1.49
The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation. J Biol Chem (1997) 1.48
Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells. Biochemistry (1976) 1.48
Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med (2003) 1.47
Properties and products of the degradation of DNA by bleomycin and iron(II). Biochemistry (1978) 1.47
Origin of malondialdehyde from DNA degraded by Fe(II) x bleomycin. J Biol Chem (1980) 1.47
Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol. Br J Cancer (1999) 1.45
Syntaxin 4 in 3T3-L1 adipocytes: regulation by insulin and participation in insulin-dependent glucose transport. Mol Biol Cell (1996) 1.45
Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther (1984) 1.44
Cognitive impairments in advanced PD without dementia. Neurology (2002) 1.44
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells. Gene Ther (2007) 1.40
Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7. J Appl Microbiol (2009) 1.40
Astrocytic gap junctions remain open during ischemic conditions. J Neurosci (1998) 1.39
Goldfinger: a framework for resolving affect using ideomotor questioning. Am J Clin Hypn (1997) 1.38
Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures. Brain Res (1981) 1.38
Downregulation of mu opioid receptor by RNA interference in the ventral tegmental area reduces ethanol consumption in mice. Genes Brain Behav (2007) 1.37
The mouse mahogany locus encodes a transmembrane form of human attractin. Nature (1999) 1.37
Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J Biol Chem (1995) 1.36
Regulation of postendocytic trafficking of the epidermal growth factor receptor through endosomal retention. J Biol Chem (1994) 1.35
Potential metabolite markers of schizophrenia. Mol Psychiatry (2011) 1.35
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia (2009) 1.34
β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br J Cancer (2013) 1.34
Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry (1978) 1.31
Complementing genomics with proteomics: the membrane subproteome of Pseudomonas aeruginosa PAO1. Electrophoresis (2000) 1.30
The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer (1997) 1.30
Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis (1993) 1.30
Integrating pharmacokinetics knowledge into a drug ontology: as an extension to support pharmacogenomics. AMIA Annu Symp Proc (2003) 1.30
Intracellular degradation of HeLa and adenovirus type 2 DNA induced by camptothecin. Biochem Biophys Res Commun (1971) 1.29
Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol (2001) 1.28
Cellubrevin is a resident protein of insulin-sensitive GLUT4 glucose transporter vesicles in 3T3-L1 adipocytes. J Biol Chem (1995) 1.28
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28